This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
PAT stood at Rs. 88 crore for Q4 FY25 as compared to Rs. 56 crore in Q4FY24, an increase of 57%
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The company is one of the most profitable companies manufacturing speciality chemicals in India
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Subscribe To Our Newsletter & Stay Updated
